G. Unal And F. Aricioglu, "A-582941, cholinergic alpha 7 nicotinic receptor agonist, improved cognitive and negative symptoms of the sub-chronic MK-801 model of schizophrenia in rats," PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.28, no.1, pp.4-13, 2018
Unal, G. And Aricioglu, F. 2018. A-582941, cholinergic alpha 7 nicotinic receptor agonist, improved cognitive and negative symptoms of the sub-chronic MK-801 model of schizophrenia in rats. PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.28, no.1 , 4-13.
Unal, G., & Aricioglu, F., (2018). A-582941, cholinergic alpha 7 nicotinic receptor agonist, improved cognitive and negative symptoms of the sub-chronic MK-801 model of schizophrenia in rats. PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.28, no.1, 4-13.
Unal, GÖKHAN, And Feyza Aricioglu. "A-582941, cholinergic alpha 7 nicotinic receptor agonist, improved cognitive and negative symptoms of the sub-chronic MK-801 model of schizophrenia in rats," PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.28, no.1, 4-13, 2018
Unal, GÖKHAN And Aricioglu, Feyza. "A-582941, cholinergic alpha 7 nicotinic receptor agonist, improved cognitive and negative symptoms of the sub-chronic MK-801 model of schizophrenia in rats." PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.28, no.1, pp.4-13, 2018
Unal, G. And Aricioglu, F. (2018) . "A-582941, cholinergic alpha 7 nicotinic receptor agonist, improved cognitive and negative symptoms of the sub-chronic MK-801 model of schizophrenia in rats." PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.28, no.1, pp.4-13.
@article{article, author={GÖKHAN ÜNAL And author={Feyza Aricioglu}, title={A-582941, cholinergic alpha 7 nicotinic receptor agonist, improved cognitive and negative symptoms of the sub-chronic MK-801 model of schizophrenia in rats}, journal={PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY}, year=2018, pages={4-13} }